Product Images Dexamethasone Sodium Phosphate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Dexamethasone Sodium Phosphate NDC 51662-1660 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

structure - 51662 1660 structure

structure - 51662 1660 structure

VIAL LABEL - 51662 1660 1 vial label

VIAL LABEL - 51662 1660 1 vial label

This text provides information about a medication called Dexamethasone. It is a solution with a concentration of 20 mg per 5 mL (4 mg/mL) and indicates that it can be used for intravenous, intramuscular, or intra-articular administration.*

RFID Label - 51662 1660 1 vial rfid

RFID Label - 51662 1660 1 vial rfid

This text provides information about a product with the manufacturer's insert information for distribution by HF Acquisitions Co., LLC based in Mukilteo, WA 98275. The text also indicates that the product is for prescription use only.*

Pouch label - 51662 1660 2 Pouch label

Pouch label - 51662 1660 2 Pouch label

This is a description of Dexamethasone Sodium Phosphate injection, USP 20mg/5mL (4mg/mL) in a 5mL vial. The medication is intended for intravenous, intramuscular, intralesional, and intra-articular soft tissue use. The product is a steroid solution equivalent to 4mg Dexamethasone Phosphate, containing Sodium Citrate Anhydrous, Benzyl Alcohol, and Water for Injection. The package insert provides instructions for proper usage, storage conditions (20 to 25 degrees Celsius), and caution to avoid freezing and exposure to light. The medicine is manufactured by HF Acquisition Co., LLC in Mukilteo, WA, 98275.*

RFID Label - 51662 1660 3 case

RFID Label - 51662 1660 3 case

This is information about Dexamethasone Sodium Phosphate Injection, USP containing 20mg/5mL (4mg/mL) in a 5mL vial. The medication is to be used for intravenous, intramuscular, intralesional, intra-articular, or soft tissue use. Each mL contains dexamethasone sodium phosphate equivalent to dexamethasone phosphate, along with other components. The product should be stored between 2 to 25 degrees Celsius, protected from light and freezing, and not autoclaved. For more details on usage and storage, refer to the package insert provided by the manufacturer, HFA Acquisition Co., LLC.*

Case Label - 51662 1660 3 case label

Case Label - 51662 1660 3 case label

This text provides information about a product identification number: (01)40351662166039 and a manufacture identification number: (10)789210. It also mentions a note to see the manufacturer's insert. The product seems to be distributed by HF Acquisitions Co., LLC based in Mukilteo, WA 98275.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.